Lv5
915 积分 2022-02-22 加入
Screening for Metabolic Dysfunction–Associated Steatotic Liver Disease–Related Advanced Fibrosis in Diabetology: A Prospective Multicenter Study
13天前
已完结
Reply to: “Transitioning FIB-4 score: From fibrosis screening tool to key biomarker for clinical endpoints”
16天前
已完结
Transitioning FIB-4 score: From fibrosis screening tool to key biomarker for clinical endpoints
16天前
已完结
The Influence of GLP-1 Receptor Agonists on Five-Year Mortality in Colon Cancer Patients
1个月前
已完结
Glucagon-like Peptide-1 Receptor Agonists and Colorectal Cancer Risk
1个月前
已完结
Reduced risks of colorectal cancer with GLP-1RAs in type 2 diabetes: A nationwide cohort study using a target trial emulation framework
1个月前
已完结
Risk for Cancer With Glucagon-Like Peptide-1 Receptor Agonists and Dual Agonists
1个月前
已完结
Response to: Breath volatile organic compound testing in colorectal cancer
1个月前
已关闭
Early-Onset Colorectal Cancer: A Review of Current Insights and a Call for Action
1个月前
已完结
Longitudinal Changes in Fibrosis Markers: Monitoring Stiffness/Fibrosis Progression and Prognostic Outcomes in MASLD
1个月前
已完结
皖公网安备34019202002308
